Pharmacists' Knowledge of CGRP Migraine Drugs: Practice Survey Results
Survey of pharmacist knowledge, attitudes, and practices toward CGRP inhibitors for migraine management reveals education gaps and practice patterns in community pharmacy.
Quick Facts
What This Study Found
Survey of pharmacist knowledge, attitudes, and practices toward CGRP inhibitors for migraine management reveals education gaps and practice patterns in community pharmacy.
Key Numbers
Cross-sectional survey of pharmacists in Saudi Arabia assessing knowledge, attitudes, and practices regarding CGRP inhibitors.
How They Did This
Study design and methodology detailed in the full publication.
Why This Research Matters
These findings are relevant to the growing population of patients using or considering peptide-based therapies.
The Bigger Picture
This study contributes to the expanding evidence for peptide-based therapeutics in clinical medicine.
What This Study Doesn't Tell Us
Study limitations discussed in the full publication.
Questions This Raises
- ?What are the long-term implications?
- ?How do results compare to existing evidence?
- ?What further research is needed?
Trust & Context
- Key Stat:
- Key finding Survey of pharmacist knowledge, attitudes, and practices toward CGRP inhibitors for migraine managem
- Evidence Grade:
- Evidence assessment based on study design in publication.
- Study Age:
- Published in 2025.
- Original Title:
- Pharmacists' Knowledge, Attitudes, and Practices Toward CGRP Inhibitors in Migraine Management: A Cross-Sectional Study.
- Published In:
- Healthcare (Basel, Switzerland), 13(17) (2025)
- Authors:
- Alfahmi, Anwar Seraj, Alqarni, Lana Abdullah, Alkhatabi, Lura Abdulrahman, Alshehri, Fahad S
- Database ID:
- RPEP-09853
Evidence Hierarchy
Frequently Asked Questions
What does this study mean for patients?
Survey of pharmacist knowledge, attitudes, and practices toward CGRP inhibitors for migraine management reveals education gaps and practice patterns in community pharmacy.
How reliable are these findings?
Consult the full publication and your healthcare provider for personalized guidance.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09853APA
Alfahmi, Anwar Seraj; Alqarni, Lana Abdullah; Alkhatabi, Lura Abdulrahman; Alshehri, Fahad S. (2025). Pharmacists' Knowledge, Attitudes, and Practices Toward CGRP Inhibitors in Migraine Management: A Cross-Sectional Study.. Healthcare (Basel, Switzerland), 13(17). https://doi.org/10.3390/healthcare13172231
MLA
Alfahmi, Anwar Seraj, et al. "Pharmacists' Knowledge, Attitudes, and Practices Toward CGRP Inhibitors in Migraine Management: A Cross-Sectional Study.." Healthcare (Basel, 2025. https://doi.org/10.3390/healthcare13172231
RethinkPeptides
RethinkPeptides Research Database. "Pharmacists' Knowledge, Attitudes, and Practices Toward CGRP..." RPEP-09853. Retrieved from https://rethinkpeptides.com/research/alfahmi-2025-pharmacists-knowledge-attitudes-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.